Recent progress in the rational design of mRNA vaccines
Molecular Therapy · 2026-10 · 34 (10) · 5652-5674
DOI: 10.1016/j.ymthe.2026.07.020 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecular Therapy, 2026-10. Verfasst von Zijia Guo und 7 weiteren Autor:innen. Beteiligte Einrichtung: National Key Laboratory of Advanced Drug Delivery and Release Systems, Zhejiang University, Hangzhou 310058, China; MOE Laboratory of Biosystems Home…. Hauptthemen laut MEDLINE: mRNA Vaccines, RNA, Messenger. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 150 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Fundamental Research Funds for the Central Universities, Zhejiang Province Natural Science Foundation.
Abstract (Originalsprache)
Messenger RNA (mRNA)-based vaccines, including circular RNA (circRNA) and self-amplifying RNA (saRNA), have emerged as the most transformative platforms, offering tremendous potential in prophylactic and therapeutic medicine, particularly in the prevention of infectious diseases and cancer immunotherapy. Nevertheless, their optimization remains limited by the instability of mRNA, its innate immunogenicity, and low protein expression efficiency in vivo. In recent years, rapid advancements in mRNA sequence design and delivery technologies have improved therapeutic protein production and enhanced vaccine efficacy and safety. This article reviews mRNA-based vaccines, including conventional non-replicating mRNA and emerging approaches such as circRNA and saRNA, with a focus on recent progress, sequence optimization, and delivery systems. Additionally, the article highlights recent advancements in computational technologies for vaccine design. Finally, the article outlines current manufacturing challenges and potential solutions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- National Key Laboratory of Advanced Drug Delivery and Release Systems, Zhejiang University, Hangzhou 310058, China; MOE Laboratory of Biosystems Homeostasis & Protection, Innovation Center for Cell Signaling Network, Co…
- Emergency and Trauma Centre, First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou 310058, China.
- Emergency and Trauma Centre, First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou 310058, China. Electronic address: zjcswk@zju.edu.cn.
Förderung
- Fundamental Research Funds for the Central Universities
- Zhejiang Province Natural Science Foundation
Zitieren
APA
Guo, Z., Fu, J., Ran, L., Bao, N., Wang, Y., Dong, H., Yang, X., & Jin, Y. (2026). Recent progress in the rational design of mRNA vaccines. Molecular Therapy, 34(10), 5652-5674. https://doi.org/10.1016/j.ymthe.2026.07.020
Vancouver
Guo Z, Fu J, Ran L, Bao N, Wang Y, Dong H, et al. Recent progress in the rational design of mRNA vaccines. Molecular Therapy. 2026;34(10):5652-5674. doi:10.1016/j.ymthe.2026.07.020
BibTeX
@article{Guo2026,
author = {Guo, Zijia and Fu, Jiayan and Ran, Luna and Bao, Nengcheng and Wang, Yadong and Dong, Haiyang and Yang, Xiaofeng and Jin, Yongfeng},
title = {Recent progress in the rational design of mRNA vaccines},
journal = {Molecular Therapy},
year = {2026},
volume = {34},
number = {10},
pages = {5652--5674},
doi = {10.1016/j.ymthe.2026.07.020}
}
EUVIMED